CarboCalyx GmbH is a glycopharmaceutical startup company dedicated for the establishment of novel immunomodulatory biologics using cellular modifications, glycoengineering and targeted immunotherapy. Our technologies are suitable for clinical testing in various disease conditions. We aim to develop personalized vaccination methodologies for patients fighting against cancer and to generate a repertoire of innovative opportunities to control infectious diseases.
